PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
申请人:Mitobridge, Inc.
公开号:US10188627B2
公开(公告)日:2019-01-29
Provided herein are compounds of formula (I) useful for the treatment of PPAR-delta related diseases (e.g. mitochondrial diseases, muscular diseases, vascular diseases, demyelinating diseases and metabolic diseases).
本文提供的式 (I) 化合物可用于治疗 PPAR-delta 相关疾病(如线粒体疾病、肌肉疾病、血管疾病、脱髓鞘疾病和代谢性疾病)。